ArticleArchives of Razi Institute2025
Infectious Bronchitis Virus in Broiler Chickens: Seroprevalence and Associated Risk Factors.
Article in Archives of Razi Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Infectious bronchitis virus (IBV) is one of the most important viral diseases, causing considerable economic losses in the poultry industry worldwide. The present study was conducted in Algeria to investigate the seroprevalence, associated risk factors, clinical signs, and lesions of IBV disease in broiler chicken. Materials & Methods: The study was conducted in 63 chicken farms, where three IBV vaccination protocols were used in the first protocol: A single H120 dose was administered to the chicks at 7 days of age, in the second protocol: H120 at 3 days with an MA5 booster at 14 days, and in the third protocol: H120 at 3 days with MA5 and 4/91 boosters at 14 and 35 days, respectively. A total of 2142 sera were collected and analyzed using the enzyme-linked immunosorbent assay (ELISA) test. Results: IBV was detected in 77.77% of broiler farms. The most common clinical signs observed were wheezing, sneezing, coughing, nasal discharge in the respiratory form, aqueous diarrhea, and dehydration in the nephropathogenic form. Lesions included tracheitis, fibrin deposition in the respiratory form, hemorrhagic nephritis, uric acid deposition at the renal, visceral, and articular level in the nephropathogenic form. Antibody titers were higher in winter compared with autumn and spring (P<0.01). Antibody titers were also higher in chickens aged >30 days, in farms with a high density, poor hygiene level, and under the first vaccination protocol, compared with chickens aged ≤30 days (P<0.01), farms with a low density (P<0.001), farms with good hygiene level (P<0.01) and those under the third vaccination protocol (P<0.01). Conclusion: These findings showed a high seroprevalence of IBV in Algeria and highlight the importance of continuous surveillance and molecular characterization of persistent strains to optimize vaccination strategies against emerging variants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.